Bio-Tech & Science Related News

  • Bioengineering progress demands global collaboration
    Bioengineering – also known as biological or biomedical engineering – has a rich history dating back to 8000BCE when humans began using selective breeding to modify plants and animals to enhance crops and livestock. The word “bioengineering”, however, didn’t emerge until 1954 when British scientist and broadcaster Heinz Wolff coined the term to describe the application of engineering
  • Boosted Pancreatic Cancer Fight: AMTB Nanoparticles
    In the relentless battle against pancreatic cancer, a novel therapeutic strategy has emerged that could revolutionize treatment outcomes. Recent research has illuminated the enhanced anti-cancer effects of AMTB hydrochloride when delivered via chitosan nanoparticles, marking a significant advancement in oncological nanomedicine. Pancreatic cancer, notorious for its aggressive nature and poor prognosis, demands innovative approaches that
  • Abiotic Lipid Metabolism Boosts Artificial Cell Flexibility
    In a groundbreaking advance at the intersection of chemistry, synthetic biology, and materials science, researchers have unveiled an artificial lipid metabolic network capable of generating and sustaining dynamic cell membranes in synthetic compartments. These artificial membranes, crafted through purely abiotic chemical processes, mimic one of the fundamental characteristics of living cells—their remarkable membrane plasticity powered
  • Health Ranger Report: Dr. Alphonzo Monzo discusses nanotechnology, 5G and the weaponization of health
    Health Ranger Report: Dr. Alphonzo Monzo discusses nanotechnology, 5G and the weaponization of health Dr. Alphonzo Monzo’s journey into biophysics and nanotechnology began after traditional medicine failed to address his ulcerative colitis, leading him to study the electromagnetic systems of the human body. Monzo warns that nanoparticles (e.g., carbon nanotubes combined with metals) can self-assemble
  • New insights into HIV-1 capsid disruption open doors for novel therapies
    Announcing a new publication for Acta Materia Medica journal. The HIV-1 capsid protein (CA) plays a crucial role in viral replication by orchestrating nuclear entry through interactions with host nuclear pore complexes (NPCs). Recent research has revealed that HIV-1 CA actively disrupts NPC architecture via phenylalanine-glycine (FG)-repeat nucleoporin interactions, thereby enabling nuclear translocation of viral